Skip Navigation

A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer Lung-MAP Screening Study

Brief Summary

Type:
Lung Cancers

Study Type:
Screening

Phase:
III

ClinicalTrials.gov Identifier:
NCT03851445

Study #:
STUDY00143485

Start Date:
Jan 29, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03851445

View Complete Trial Details & Eligibility at ClinicalTrials.gov